2nd Quarter - Report

COVINGTON & BURLING LLP for ADAMIS PHARMACEUTICALS CORPORATION

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Legislation and rulemakings relating to opioid abuse and Naloxone access; H.R. 4007, the HEAL Act; H.R. 4531, the Support for Patients and Communities Reauthorization Act.

LobbyistCovered position, as disclosed
GARY HEIMBERG —
GABRIEL NEVILLE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 4007 (118th), H.R. 4531 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.